ArticleCase reports in medicine2026
Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection: A Case Report.
Article in Case reports in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Successful Treatment of Multiple Myeloma Complicated With SARS-CoV-2 Infection: A Case Report.Case reports in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since the declaration of the coronavirus disease 2019 (COVID-19) pandemic in late 2019, COVID-19 has remained a global concern. Elderly patients with hematological malignancies are immunocompromised and thus highly susceptible to COVID-19 infection and severe acute respiratory syndrome (SARS), posing significant clinical challenges. This report describes the diagnosis and treatment of a patient with multiple myeloma (MM) who developed SARS-CoV-2 infection. Methods: We collected general patient information, clinical features, laboratory results, chest CT imaging, electronic bronchoscopy results, and clinical results for analysis. This case report was approved by the Institutional Review Committee of Baiyin First People's Hospital, and informed consent was obtained from the patient. Outcomes: We report a case of a 66-year-old male newly diagnosed with multiple myeloma who developed a SARS-CoV-2 infection following chemotherapy. His clinical condition showed marked improvement after the initiation of nirmatrelvir/ritonavir therapy. This case underscores the heightened susceptibility of immunocompromised patients to SARS-CoV-2 and highlights the therapeutic importance of early administration of antiviral agents. A comprehensive understanding of the increased risk of opportunistic infections in patients with multiple myeloma postchemotherapy is essential for optimizing disease management and improving clinical outcomes. Conclusion: Patients with MM have impaired immune function and are at high risk for severe infections during treatment. Proactive infection prevention and early intervention are essential to improving outcomes during treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.